Presentation is loading. Please wait.

Presentation is loading. Please wait.

(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...

Published byRasmus Bengtsson Modified over 6 years ago

Similar presentations

Presentation on theme: "(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ..."— Presentation transcript:

1 (A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...
(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF in DESIR; (D) LSF in SPACE. The dotted lines represent the percentile curves derived from healthy individuals (percentiles indicated) and the help-lines (a′; to d′; ), parallel to the percentile curves. The coloured solid lines represent all the real measurements of mSchober and LSF by patient in DESIR (left) and SPACE (right). There is a high variability of the spinal mobility measurements over time in both cohorts. LSF: lateral spinal flexion. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Rheumatology (Oxford), kez026, The content of this slide may be subject to copyright: please see the slide notes for details.

2 (A) mSchober in DESIR; (B) ...
(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF in DESIR; (D) LSF in SPACE. The dotted lines represent the percentile curves derived from healthy individuals (percentiles indicated) and the help-lines (a′; to d′; ), parallel to the percentile curves. The coloured solid lines represent all the real measurements of mSchober and LSF by patient in DESIR (left) and SPACE (right). There is a high variability of the spinal mobility measurements over time, even when plotting only patients with a controlled disease activity (ASDAS < 2.1 in ≥2/3 of visits). ASDAS: Ankylosing Spondylitis Disease Activity Score; LSF: lateral spinal flexion. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Rheumatology (Oxford), kez026, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ..."

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.

(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.
(A) Calcinosis cutis on the extensor side of the left upper arm ...

(A) Calcinosis cutis on the extensor side of the left upper arm ...
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Figure 1 Phases of the research. Author’s own work.

Figure 1 Phases of the research. Author’s own work.
(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.

(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.
Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.
Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.
Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.
Source: Figure created by the author based on data ...

Source: Figure created by the author based on data ...
(A) OA patients with ... (A) OA patients with crystals exhibit an increase in FA levels in SF compared with OA patients without crystals. (B) Patients.

(A) OA patients with ... (A) OA patients with crystals exhibit an increase in FA levels in SF compared with OA patients without crystals. (B) Patients.
bDMARD: biologic DMARD.

bDMARD: biologic DMARD.

Similar presentations

Ads by Google